Biotechnology, Cell culture, Protein, DNA, Cell, Protein targeting

Working Smarter and Quicker with this Protein Purification Platform

On Jan 26, 2021
@Labiotech_eu shared
Purification of proteins and antibodies is an essential task in many labs. But the current process is cumbersome. Can this novel protein purification system help? 🧐 https://t.co/1MwZlwIdVc #biotech @GenscriptE
Open

Protein and antibody purification is an essential task in many laboratories, but it’s also cumbersome. Can this new platform help?

www.labiotech.eu
On Jan 26, 2021
@Labiotech_eu shared
Purification of proteins and antibodies is an essential task in many labs. But the current process is cumbersome. Can this novel protein purification system help? 🧐 https://t.co/1MwZlwIdVc #biotech @GenscriptE
Open

Working Smarter and Quicker with this Protein Purification Platform

Working Smarter and Quicker with this Protein Purification Platform

Protein and antibody purification is an essential task in many laboratories, but it’s also cumbersome. Can this new platform help?

Senior Scientist: Protein Purification

Senior Scientist: Protein Purification

We are seeking a skilled and experienced senior researcher to join a team focused on the expression and purification of human expressed proteins.

Cell-free is growing up

Cell-free is growing up

Cell-free technology can increase the ease and speed of discovery and better prepare the next generation of scientists for the challenges ahead.

Single Cell Genomics and Proteomics Market Recent Trends & Demand by 2026| Agilent Technologies, Inc., Merck KGaA, Danaher, WATERS

Single Cell Genomics and Proteomics Market Recent Trends & Demand by 2026| Agilent Technologies, Inc., Merck KGaA, Danaher, WATERS

Single Cell Genomics and Proteomics Market research report involves six major parameters namely market analysis, market definition, market segmentation, key developments in the market, ...

The Dish’s Weekly Biotechnology News Wrap Up – November 15, 2019

The Dish’s Weekly Biotechnology News Wrap Up – November 15, 2019

0 0 0 Total: 0 This week’s headlines include: CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US, FDA grants Sandoz approval for Ziextenzo in oncology care, Takeda ...

Unpicking the proteome in single cells

Unpicking the proteome in single cells

Recently, the throughput of single-cell RNA-sequencing (transcriptomics) and genomics technologies has increased more than a 1000-fold. This increase has powered new analyses: Whereas ...

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

Many drugs work by binding to a protein and blocking it. Technology for eliminating disease-causing proteins altogether remains experimental, but this

Syngene Biotechnology Job – Associate Scientist-Protein Purification Post

Syngene Biotechnology Job – Associate Scientist-Protein Purification Post

Syngene International Ltd. is currently hiring for Associate Scientist-Protein Purification Post.  Syngene Biotechnology Job 2020.

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A ...

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs, which are designed to make the cell degrade harmful proteins to treat cancer. ...

Fully Automated Luxury Drug Discovery

Fully Automated Luxury Drug Discovery

Drug discovery still poses difficulties, but some of the toil is shifting to artificial intelligence and robotic systems. Also, some tasks can be eased by using clever mass spectrometry and ...

Navigo Proteins and Repligen Announce Achievement of a Key Milestone in Development of an Affinity Resin for the Purification of COVID-19 Vaccines

Navigo Proteins and Repligen Announce Achievement of a Key Milestone in Development of an Affinity Resin for the Purification of COVID-19 Vaccines

Navigo Proteins and Repligen Corporation announced their successful development of an affinity ligand targeting the SARS-CoV‑2 spike protein, to be utilized in the purification of COVID-19 ...

From Farm to Finger Prick—A Perspective on How Plants Can Help in the Fight Against COVID-19

From Farm to Finger Prick—A Perspective on How Plants Can Help in the Fight Against COVID-19

As a consequence of the COVID-19 pandemic crisis, farmers across the country are plowing under their fields and laying off workers. Plant biomass has been shown by the DARPA “Blue Angel” ...